Tvardi Therapeutics, Inc 10-K for FY2024
Tvardi Therapeutics, Inc. (TVRD)
10-K
2025-03-11
For: 2024-12-31
View Original
Added on
April 09, 2026
About this 10-K
Tvardi Therapeutics, Inc filed this 10-K on March 11, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $7.14M
- down 66.0% from $20.97M a year earlier
- Net loss
- $70.87M
- compared with a net loss of $118.51M a year earlier
- Diluted EPS
- -$15.53
- compared with -$26.26 a year earlier